Convertible notes and Simple Agreements for Future Equity (SAFEs) are two popular instruments used by startups and early-stage companies to raise financing, typically before they secure more substantial funding rounds. These instruments are favoured for their flexibility and simplicity compared to traditional equity financing. However, the use of convertible notes and SAFEs comes with various legal implications, and understanding these is crucial for both founders and investors. In this discussion, we will explore the legal ramifications of using convertible notes and SAFEs in early-stage financing, looking at the risks, benefits, and key terms associated with these instruments, and how they interact with corporate law in the United Kingdom.
Introduction to Convertible Notes and SAFEs
Convertible notes and SAFEs are financial instruments designed to bridge the gap between seed funding and subsequent, more significant rounds of investment. Unlike conventional equity financing, these instruments do not immediately assign equity to investors. Instead, they defer the valuation and equity conversion until a later funding event or maturity. In essence, they allow startups to secure funding without the need to negotiate an exact valuation at an early and often precarious stage of business development.
- Convertible Notes: Convertible notes are essentially short-term debt instruments that convert into equity at a later stage, typically during the company’s next round of financing. This conversion usually happens at a discount or with a valuation cap, providing an incentive for early investors.
- SAFEs: A SAFE, in contrast, is not debt but a contract that grants the investor the right to receive equity at a future event, often without the repayment obligation that comes with convertible notes. SAFEs also often include a valuation cap or discount mechanism, but they do not accrue interest or have a maturity date, making them more straightforward in some respects.
While both instruments are considered favourable due to their flexibility, the legal implications can be significant for both companies and investors. The simplicity of these agreements can sometimes mask complex legal outcomes, particularly if the startup does not achieve the anticipated funding rounds or growth.
Legal Structure of Convertible Notes
Convertible notes are structured as debt instruments, which means they include provisions for repayment, interest accrual, and a maturity date. The primary legal concern for startups is that, as debt, convertible notes must be repaid if they do not convert to equity. This creates a potential liability on the company’s balance sheet.
2.1 Key Legal Terms
Some of the critical legal terms in a convertible note include:
- Interest Rate: Convertible notes accrue interest over time. Upon conversion, this interest is typically added to the principal and converted into equity. The interest rate must be legally compliant with local regulations, and if set too high, it could burden the startup.
- Maturity Date: The maturity date is when the note becomes due for repayment. If the startup does not raise a subsequent round of financing before the maturity date, the noteholders could demand repayment, which could lead to insolvency if the company lacks sufficient funds.
- Valuation Cap: The valuation cap sets a ceiling on the price at which the note will convert into equity. This term provides early investors with protection against dilution in the event of a high valuation during subsequent funding rounds.
- Discount Rate: A discount rate allows investors to convert their debt into equity at a price lower than the future valuation during a qualifying financing round. The rate is typically set between 10-30%, rewarding investors for their early risk.
2.2 Repayment and Insolvency Risks
One of the critical legal issues with convertible notes is the possibility of insolvency if the note reaches its maturity date and the company is unable to convert the note into equity. Convertible notes are still, at their core, debt instruments. If the company has not secured sufficient subsequent financing, it may face the obligation to repay the note’s principal and accrued interest. This can create serious financial strain, particularly for startups that may not yet have significant revenue.
UK insolvency laws come into play here. If a company is unable to meet its debt obligations, it may be forced into liquidation, which could result in significant losses for both the company and its investors. Investors should be aware of the potential risk that their convertible note may never convert into equity if the company fails to reach a qualifying financing event before the maturity date.
Legal Structure of SAFEs
SAFEs, as opposed to convertible notes, are not debt instruments. They do not come with an obligation to repay the investor or accrue interest. This simplicity is one of the main reasons why SAFEs have become increasingly popular, particularly in tech startups. However, while they are simpler, they are not without legal complexities.
3.1 Key Legal Terms
The key legal terms in a SAFE agreement typically include:
- Valuation Cap: Like convertible notes, SAFEs often include a valuation cap, which sets the maximum valuation at which the investor’s SAFE will convert into equity. This protects early investors from excessive dilution if the startup’s valuation increases significantly before the next financing round.
- Discount Rate: SAFEs may also include a discount rate, allowing investors to receive equity at a reduced price when the conversion event occurs.
- Conversion Trigger: The SAFE converts into equity when a specified triggering event occurs, such as a future round of equity financing or an acquisition. It’s important to clearly define what constitutes a triggering event to avoid legal disputes.
- Liquidity Events: In some cases, SAFEs provide for conversion or repayment in the event of a liquidity event, such as a sale or dissolution of the company, before a funding round. This can raise legal questions regarding the priority of claims, especially if there are other creditors.
3.2 Differences from Convertible Notes
The lack of a maturity date and the fact that SAFEs are not considered debt instruments mitigate some of the risks associated with convertible notes. There is no risk of insolvency due to the inability to repay debt, as there is no repayment obligation. However, this also means that SAFEs are less favourable to investors in scenarios where the company does not achieve a conversion event in a reasonable timeframe. Investors holding SAFEs could theoretically hold their instruments indefinitely without receiving equity or repayment.
Regulatory Implications in the United Kingdom
In the United Kingdom, companies issuing convertible notes and SAFEs must ensure compliance with corporate and securities laws. While the UK offers a relatively startup-friendly environment, there are several regulatory frameworks that both startups and investors need to navigate.
4.1 Companies Act 2006
The Companies Act 2006 governs most corporate activities in the UK, including the issuance of shares. Convertible notes and SAFEs can have significant implications for a company’s share capital, particularly when they convert into equity. Directors must ensure they have the authority to issue shares under the company’s articles of association, and in some cases, shareholder approval may be required. Additionally, pre-emption rights, which give existing shareholders the right to purchase new shares before outsiders, must be considered.
4.2 Securities Law
The issuance of convertible notes and SAFEs may also raise issues under UK securities law. These instruments could be considered a type of security, which may necessitate compliance with disclosure and regulatory requirements, especially if the fundraising is offered to a broad group of investors rather than a select few. Startups must be cautious when marketing these instruments to ensure they are not inadvertently violating laws that regulate the offering of securities to the public.
4.3 Tax Implications
Convertible notes and SAFEs can also have tax implications for both the company and the investors. For instance, the interest accrued on a convertible note may be treated as income and subject to tax. On the other hand, the eventual conversion of either instrument into equity may trigger tax obligations depending on the circumstances.
In the UK, entrepreneurs’ relief and the Enterprise Investment Scheme (EIS) provide tax relief to investors in certain qualifying companies. Investors who hold shares in companies that qualify under these schemes may benefit from significant tax breaks. However, convertible notes and SAFEs may not always qualify for these schemes, particularly if the terms do not align with the stringent conditions of the EIS or Seed Enterprise Investment Scheme (SEIS).
Risk of Dilution and Control
Convertible notes and SAFEs can lead to significant dilution for founders, particularly if the startup raises multiple rounds of financing. Valuation caps and discounts incentivise early investment but may also result in early investors receiving a disproportionately large share of equity, especially if the company’s valuation grows substantially.
5.1 Dilution Risk
The conversion of convertible notes and SAFEs can result in unexpected levels of dilution for founders if the valuation caps are set too low. For example, if a company raises significant capital in a subsequent round of funding at a much higher valuation, early investors with SAFEs or convertible notes that have low valuation caps will receive a large proportion of the equity. This can reduce the founder’s ownership stake significantly, which may affect control of the company.
5.2 Control and Governance
Beyond dilution, the use of convertible notes and SAFEs can also affect the governance of the company. In some cases, investors may seek additional rights as part of their investment, such as board seats or veto rights over certain decisions. These governance provisions can affect the founder’s ability to control the direction of the company.
Moreover, the conversion of notes or SAFEs into equity during a subsequent funding round can lead to the creation of different classes of shares. For example, investors in later rounds may receive preferred shares with voting rights or liquidation preferences, further diluting the founders’ control over key business decisions.
Legal Disputes and Litigation Risk
Although convertible notes and SAFEs are generally seen as simpler than traditional equity financing, they can still lead to legal disputes. Misunderstandings over key terms, such as valuation caps, conversion triggers, and repayment obligations, can result in costly litigation for both startups and investors.
6.1 Misalignment of Expectations
One of the most common sources of legal disputes is a misalignment of expectations between founders and investors. Investors may expect to receive equity within a certain timeframe, while founders may assume that the absence of a maturity date or repayment obligation in a SAFE means they can delay equity conversion indefinitely. Clearly defining the terms of conversion and setting expectations early on is essential to avoiding such disputes.
6.2 Enforceability of Terms
The enforceability of key terms, such as conversion triggers or discount rates, can also be subject to legal challenge. In some cases, investors may seek to enforce their rights to convert debt into equity even if the company has not raised a subsequent round of financing. Conversely, startups may seek to challenge the valuation cap or discount terms if they feel that these terms are unfairly diluting their ownership.
Disputes can also arise over the valuation of the company at the time of conversion, particularly if the company has undergone significant changes since the note or SAFE was issued. For example, if the company has pivoted to a new business model or experienced a significant change in management, the valuation at the time of conversion may not reflect the company’s earlier state.
Conclusion
Convertible notes and SAFEs are highly flexible instruments that provide startups with much-needed financing during their early stages. However, their simplicity can sometimes mask complex legal risks. Startups and investors alike need to be aware of the potential pitfalls, from repayment obligations and dilution to regulatory compliance and taxation.
Convertible notes carry the risk of insolvency if the startup is unable to convert the note into equity or raise sufficient funds for repayment. SAFEs, while simpler, can lead to indefinite periods where investors are neither repaid nor converted into equity. Both instruments also carry risks related to dilution and control, which can affect the long-term governance and financial health of the startup.
In the UK, compliance with corporate and securities laws is crucial, and both companies and investors should seek legal advice to ensure they are meeting their obligations under the Companies Act 2006 and relevant securities regulations. Startups should also be mindful of the tax implications of these instruments, particularly if they are seeking to qualify for tax relief schemes such as the EIS or SEIS.
Ultimately, while convertible notes and SAFEs offer a way for startups to access financing without immediately issuing equity, both parties must carefully consider the legal implications to avoid disputes and ensure that their interests are protected in the long term.